Documents disclosed here under US Freedom of Information show the US Centers for Disease Control [CDC] spends US tax dollars in foreign countries on studies to claim the vaccination programmes they promote for US children are safe when they know the results of the studies will produce false and misleading negative results.
Just such a study recently published from Italy funded by the US CDC claims to show that the known neurotoxic mercury additive in vaccines, Thiomersal, is not harmful to children and the study has received wide-spread publicity ["Neuropsychological Performance 10 Years After Immunization in Infancy With Thimerosal-Containing Vaccines" Tozzi et al, Pediatrics 123:2:475-482].
Mercury is toxic in parts per billion. What the US public were not told is that the study was certain to be unable to detect any effect. The US CDC internal email exchange disclosed here [see more below] obtained under US Freedom of Information shows that to be able to detect any effect in children with the methods used, the dose applied by the age of 3 months had to be more than 50 millionths of a gramme of mercury and more than 100 millionths of a gramme by the age of 6 months.
Table 1 of the paper shows Italian children received by the age of 3 months two thirds of that minimum amount; no more 37.5 millionths of a gramme. By 4 months they had only three quarters of that minimum: 75 millionths of a gramme and the maximum by six months was 100 millionths of a gramme, not enough to hit or exceed the threshold needed.
The 2001 exchange of emails was between Dr Thomas Verstraeten and Dr Robert Chen of the US CDC and Dr Elizabeth Miller of the UK’s Public Health Laboratory Service. This also shows a dose of 75 microgrammes of mercury by the age of four months was insufficient to detect an effect. Chen and Miller were at the time looking into a possible study of British children. Italian infants were in the same category as British infants, receiving 75 microgrammes by the age of 4 months.
Do not be deceived into thinking there are no problems with the lower levels of mercury. Studies like this Italian one and previous internal studies by the US CDC are unable to measure the effects at lower levels. It is an issue of precision - not absence of effect.
There were many other deficiencies in the Italian study. The Journal, Pediatrics has today published a letter entitled “This study is misleading and was not scientifically worth doing” [John Stone, Pediatrics Online, 27 Jan 2009].
Notably, the study only included healthy children in the original vaccine trial so those most at risk were excluded. The authors also missed out large numbers of other children most likely to be at risk. Children excluded from the study included:
an unknown number of underweight children who are likely to be more susceptible to injury
the body burden of mercury would be proportionately higher
underweight children are likely to include premature infants - [whose effective age is less and who are underdeveloped by the time they are vaccinated compared to full-term infants]
all unwell children at time of vaccination (susceptible group)
over 30% of children dropped out of the study and the authors acknowledged these may have included those injured, the parents not participating “because their children had cognitive developmental problems“
here was no proper control group to make a comparison
the authors compared children who had mercury containing vaccines not against children who had no vaccines or no mercury but against children who had different vaccines with less mercury
Only one case of autism was identified from medical records out 1,704 (an order of magnitude lower than the UK and the US) which also casts doubts on the value of the study.
Fooling Third World Governments
The British study the US CDC was involved with with Dr Elizabeth Miller went ahead and also claimed to find no problems. It was used to reassure third world governments that mercury in vaccines was safe. It claimed the UK level of mercury was the same as the amount of thimerosal used by developing countries that follow the World Health Organisation’s expanded immunization schedule. It was not. Disclosed here is information under UK Freedom of Information showing the WHO schedule exposes the less well fed and more susceptible third world infants to 187.5µg of mercury but by 14 weeks, not 6 months. Third world children are at a much higher risk than US children ever were.
The US Centers For Disease Control and Drug Companies
This is not the first time the US CDC has been mired in controversy over mercury in vaccines. On 7-8 June 2000, a confidential private meeting without public scrutiny took place between vaccine manufacturers’ representatives, 51 US scientists, and a representative of the World Health Organization. This was to discuss a study by US Centers for Disease Control expert Dr Thomas Verstraeten of increasing doses of Thimerosal and neurodevelopmental disorders in children. Verstraeten used US Vaccine Safety Datalink (VSD) data, an official US governmental data bank on the children from US health maintenance organizations (HMOs).
Verstraeten’s study showed a dose-response relationship between Thimerosal in vaccines and neurodevelopmental disorders in children that held up to rigorous statistical analyses. This means Verstraeten’s study showed a causal association between the amount of Thimerosal in vaccines a child received and the extent to which the child developed the symptoms of impaired brain development . These ranged from tics, speech impairment to symptoms of and full autism. The discussions can be read in the transcript of the Simpsonwood Conference obtained by US organisaton SafeMinds under Freedom of Information.
Three years later Dr Thomas Verstraeten, MD, MSc [now working for GlaxoSmithKline Biologicals, Belgium] published a different paper in the journal Pediatrics: ["Safety of thimerosal-containing vaccines: a two-phased study of computerized health maintenance organization databases". Verstraeten T, Davis RL, DeStefano F, et al. Pediatrics.2003; 112 :1039 –1048]. The new paper included another set of data from a third HMO, reorganised the criteria for inclusion of children and restructured the patient groupings, and a less than statistically significant link was demonstrated. It was heavily criticised by campaigners and concerned experts. Verstraeten published a vigorous letter in his defence in which he rejected any suggestion of impropriety: ["Thimerosal, the Centers for Disease Control and Prevention, and GlaxoSmithKline"]: PEDIATRICS Vol. 113 No. 4 April 2004, pp. 932.
What can be said about this? When Verstraeten was a public official working for the US CDC there was a serious problem. When Verstraeten was working for GlaxoSmithKline there was no problem.
Vaccine Risks Outweigh Risk of Disease
Autism - A serious problem being ignored
19 Children A Day - 4 in 5 is a Boy
Autism in Britian outstrips all other major disorders affecting British children combined and is substantially more serious than measles. Every day 19 British children develop autism spectrum disorders:
* this will be 600,000 British children and adults in the future (birth rate approx 600,000 p.a.)
* and horrific prospects for expectant parents
o 1 in every 54 boys will be on the Autistic Spectrum
o autism affects 4 times as many boys
o so 1 in 215 girls are affected as well
[* 19 a day and 1 in 54 come from: Baird et Al Prevalence of disorders of the autism spectrum in a population cohort of children in South Thames: the Special Needs and Autism Project (SNAP); Lancet 2006;368:210 –15. This research revealed 1 in 86 British children are being diagnosed with autistic spectrum disorders (116.1 in 10,000).
4/5 x 116.1/5000 = 1 in 54 (4/5ths of the 116.1 are boys and approx 5000 of the 10,000 children affected will be boys)]
See here how the risk to children in Western economies from measles is now insignificant for the vast majority Measles - The Official UK Statistics.
For the USA seeUS Measles Data and generally see Risk to Children & Government Scaremongering.
Mercury in British Vaccines, Autism and Your Child’s Allergies
[First Exclusive Worldwide Revelations By ChildHealthSafety 22/Jan/2009]
In addition to the new MMR vaccine, in 1990 infants were also “hit” with the “accelerated” DTP vaccine schedule - receiving three DTP shots - one each at 2, 3 and 4 months. Prior to this the intervals were 3, 5 and 9 to 12 months of age. The DTP vaccine contained a highly neurotoxic ingredient. The ingredient was an organo-mercury excipient called “Thiomersal” ["Thimerosal" in the USA]. Thiomersal is toxic in parts per billion - in extremely small dilutions. The vaccine was The Wellcome Foundation’s Trivax AD DTP vaccine. The Wellcome Foundation is now GlaxoSmithKline. Thiomersal was first introduced by pharmaceutical company Merck in the 1930s and was not clinically trialled for safety in use in vaccines.
Research shows that children with autism appear to have deficient mechanisms for expelling toxins like mercury and it accumulates in the body.
Revealed by ChildHealthSafety exclusively worldwide for the first time [22/Jan/09] information obtained under the UK’s Freedom of Information confirms the British MHRA [Medicines and Healthcare Products Regulatory Agency] has no data on how much Thiomersal was in Trivax AD DTP vaccine. Although the British DoH [Department of Health] claimed publicly to have known, that claim therefore appears incorrect.